Drug Profile
Research programme: phosphodiesterase 10A inhibitors - Memory Pharmaceuticals
Alternative Names: PDE 10A inhibitors - MemoryLatest Information Update: 14 Mar 2008
Price :
$50
*
At a glance
- Originator Memory Pharmaceuticals
- Class Small molecules
- Mechanism of Action Phosphoric diester hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Psychotic disorders
Most Recent Events
- 28 Feb 2005 Preclinical trials in Psychotic disorders in USA (PO)